WELL Health Technologies (TSE:WELL) PT Lowered to C$11.00

WELL Health Technologies (TSE:WELL) had its target price cut by Stifel Nicolaus from C$12.00 to C$11.00 in a research note issued to investors on Wednesday morning, BayStreet.CA reports. They currently have a buy rating on the stock.

Other equities analysts have also issued reports about the stock. TD Securities increased their price target on shares of WELL Health Technologies from C$7.50 to C$8.50 and gave the company a buy rating in a research note on Wednesday, July 19th. CIBC dropped their target price on shares of WELL Health Technologies from C$7.50 to C$6.50 in a research report on Friday, August 11th. Haywood Securities boosted their price target on shares of WELL Health Technologies from C$8.00 to C$8.50 in a research report on Friday, August 11th. Finally, Pi Financial raised their price objective on WELL Health Technologies from C$7.75 to C$8.25 in a report on Friday, August 11th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of Moderate Buy and a consensus price target of C$7.67.

WELL Health Technologies Trading Up 2.7 %

TSE:WELL opened at C$3.81 on Wednesday. WELL Health Technologies has a 1 year low of C$2.56 and a 1 year high of C$5.94. The stock has a market cap of C$907.58 million, a P/E ratio of -190.50, a P/E/G ratio of -1.93 and a beta of 1.21. The company has a debt-to-equity ratio of 42.90, a quick ratio of 1.02 and a current ratio of 1.09. The stock has a 50-day simple moving average of C$4.08 and a 200-day simple moving average of C$4.51.

About WELL Health Technologies

WELL Health Technologies Corp. operates as a practitioner focused digital health company in Canada, the United States, and internationally. It offers omni-channel healthcare services, including primary care and allied health clinic operations; gastrointestinal, and mental disorders; specialized care, including gastroenterology anesthesia services; diagnostic services related to cardiology, women's health, and bone/muscle health and cancer diagnostics; and telehealth services.